Related Experiment Video
Updated: May 30, 2026

High-speed Video Microscopy Analysis for First-line Diagnosis of Primary Ciliary Dyskinesia
Published on: January 19, 2022
Difficulties in diagnosing slowly progressive mucopolysaccharidosis VI: A case series
Maurizio Scarpa1, Ebba Buffone, Philipp La Marca
1Department of Pediatrics, University of Padova, Padova, Italy.
Abstract:
An Erratum for this article can be found here: http://iospress.metapress.com/content/e16437020701m0u5/?p=df8dd6709cf44367a0c0e5d917aaeddf&pi=11We describe the cases of two adult sisters recently diagnosed with the attenuated form of mucopolysaccharidosis VI (MPS VI, Maroteaux-Lamy syndrome). MPS VI is a rare, clinically heterogeneous lysosomal storage disorder that is characterized by a deficiency in the glycosaminoglycan-degrading enzyme arylsulfatase B. Both cases had been misdiagnosed for over 30 years despite the presence of several characteristics of the disease, including short stature (mild), coarse facial features, skeletal dysmorphisms, carpal tunnel syndrome, heart valve disease, and spinal cord compression, which together are suggestive of a lysosomal storage disease. Awareness about the clinical features of MPS VI should be communicated amongst treating neurologists, rheumatologists and other specialists who are involved in the healthcare decisions of these patients with presenting symptoms, so they can refer them to specialized centers for proper diagnosis and treatment.
Insights
Two sisters with attenuated mucopolysaccharidosis VI (MPS VI) were diagnosed late, highlighting the need for increased awareness of this rare lysosomal storage disorder among specialists.
Area of Science:
- Medical Genetics
- Biochemistry
- Rare Diseases
Background:
- Mucopolysaccharidosis VI (MPS VI), also known as Maroteaux-Lamy syndrome, is a rare, heterogeneous lysosomal storage disorder.
- It results from a deficiency in the enzyme arylsulfatase B, crucial for glycosaminoglycan degradation.
Purpose of the Study:
- To report two cases of adult sisters with the attenuated form of MPS VI.
- To emphasize the diagnostic challenges and the importance of recognizing clinical features suggestive of MPS VI.
Main Methods:
- Case report detailing the clinical presentation and diagnostic journey of two affected sisters.
- Review of characteristic clinical manifestations associated with MPS VI.
Main Results:
- Both sisters were misdiagnosed for over 30 years.
- Presenting symptoms included mild short stature, coarse facial features, skeletal dysmorphisms, carpal tunnel syndrome, heart valve disease, and spinal cord compression.
Conclusions:
- Late diagnosis of attenuated MPS VI is common due to its heterogeneous presentation.
- Increased awareness of MPS VI clinical features among neurologists, rheumatologists, and other specialists is crucial for timely referral and diagnosis.
More Related Videos
Related Concept Videos
Lysosomal Hydrolases
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Huntington Disease l: Introduction
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Chronic Pancreatitis II: Pathophysiology

